References
[1] MCINNES I B. COVID-19 and rheumatology: first steps towards a different future?[J]. Ann Rheum Dis, 2020, 79(5): 551-552.
[2] XU P, ZHOU Q, XU J. Mechanism of thrombocytopenia in COVID-19 patients[J]. 2020:
[3] LIPPI G, PLEBANI M, HENRY B M. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis[J]. Clin Chim Acta, 2020, 506: 145-148.
[4] LIU Y, SUN W, GUO Y, et al. Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study[J]. Platelets, 2020, 0(0): 1-7.
[5] JIANG N, LI M, ZHANG M, et al. Chinese SLE Treatment and Research group (CSTAR) registry: Clinical significance of thrombocytopenia in Chinese patients with systemic lupus erythematosus[J]. PLoS One, 2019, 14(11): e0225516.
[6] CHEN Z, ZHONG H, DONG G. Thrombocytopenia as a Prognostic Marker for Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis[J]. Am J Med Sci, 2019, 357(6): 461-467.